Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07442851 · ClinicalTrials.gov registry record · NA
SickleFit Exercise and Nutrition Study
A NA study, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07442851: Recruiting NA study, sponsored by Duke University.
NCT07442851 is a NA study that is actively recruiting participants, run by Duke University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07442851, a NA study, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
To goal of this study is to pilot the SickleFit exercise and nutrition intervention in adults with sickle cell disease in a randomized control trial
Primary Outcome
Feasibility of randomization (proportion of participants randomized out of those approached)
Interventions
- BEHAVIORAL SickleFit Exercise plus Nutrition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-04-08 |
| Est. Completion | 2028-01 |
| Phase | NA |
What NCT07442851 shows while recruiting
NCT07442851 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which SickleFit Exercise plus Nutrition is the first listed.
NCT07442851 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07442851 about?
NCT07442851 is a clinical study titled "SickleFit Exercise and Nutrition Study". To goal of this study is to pilot the SickleFit exercise and nutrition intervention in adults with sickle cell disease in a randomized control trial
What is the current status of trial NCT07442851?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-04-08. Estimated completion is 2028-01.
What interventions are being tested in trial NCT07442851?
The interventions under investigation include: SickleFit Exercise plus Nutrition (BEHAVIORAL).
Who is sponsoring clinical trial NCT07442851?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07442851's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI